A team of researchers have created an artificial enzyme that could help form a new treatment for the neurodegenerative Parkinson’s disease. The team from Johns Hopkins Medicine have created the enzyme which stops misfolded alpha-synuclein – the protein that causes Parkinson’s disease – from spreading. The alpha-synuclein protein travels from the gut to the brain [ ]
The post Artificial enzyme could lead to new Parkinson’s disease treatment appeared first on Health Europa.
Monday 25 January 2021
healtheuropa - 19 days ago
Artificial enzyme could lead to new Parkinson’s disease treatment
Latest News
